RAPP
RAPP
US75383L1026
Rapport Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.47B EUR
2B EUR
1.5B EUR
1.45B EUR
Enterprise Value
1.01B EUR
1.94B EUR
1.43B EUR
1.41B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-6.03x
--
--
--
Price to Sales
73.53x
99.91x
74.79x
--
Price to Book
3.48x
4.72x
3.17x
2.99x
EV/Revenue
50.31x
97.24x
71.43x
--
EV/EBITDA
-6.6x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-3.81%
-4.86%
-5.4%
-4.66%
ende